Editor's Choice
M-A: Gestational diabetes mellitus and adverse pregnancy outcomes.
27 May, 2022 | 12:25h | UTC
Commentary on Twitter
NEW research finds gestational diabetes is associated with increased odds of a range of complications for both mother and baby, including caesarean delivery, severe breathing problems, and excessive birth weight https://t.co/oyzkFxMslc
— The BMJ (@bmj_latest) May 26, 2022
RCT: Vitamin D does not prevent type 2 diabetes in high risk adults, trial finds.
27 May, 2022 | 12:24h | UTCNews Release: Vitamin D does not prevent type 2 diabetes in high risk adults, trial finds – BMJ
Original Study: Effect of active vitamin D treatment on development of type 2 diabetes: DPVD randomised controlled trial in Japanese population – The BMJ
Editorial: Vitamin D and risk of type 2 diabetes – The BMJ
Cohort Study: Maternal over-the-counter analgesics use during pregnancy and adverse perinatal outcomes.
27 May, 2022 | 12:22h | UTCNews Release: Painkiller advice for pregnant women should always be followed, as use is linked to newborn problems – University of Aberdeen
Related:
Paracetamol use during pregnancy — a call for precautionary action – Nature Reviews Endocrinology
Editorial: Caution needed: paracetamol use in pregnancy – Nature Reviews Endocrinology
Dairy consumption and risks of total and site-specific cancers in Chinese adults: an 11-year prospective study of 0.5 million people.
27 May, 2022 | 12:20h | UTCNews Release:
Dairy products linked to increased risk of cancer – University of Oxford
Commentary:
Pivot into COVID-19 research eases as publishing surge starts to level off – Researchers who jumped into the field from distant disciplines published lower impact work, study finds.
27 May, 2022 | 12:18h | UTCPivot into COVID-19 research eases as publishing surge starts to level off – Science
Right ventricular failure is strongly associated with mortality in patients with moderate-to-severe COVID-19-related ARDS and appears related to respiratory worsening.
27 May, 2022 | 12:17h | UTC
Commentary on Twitter
RV failure in moderate-to-severe #COVID19 #ARDS
➡️strong predictor of mortality
➡️significant worsening of PaO2/FiO2, PaCO2 & ventilatory ratio (⬆️ pulm vasoconstriction) & ⬆️ driving P could contribute#POCUS mandatory especially if resp deterioration.
📎 https://t.co/OE56BuxeWz pic.twitter.com/dNIeo1yHcP— Intensive Care Medicine (@yourICM) May 16, 2022
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019.
27 May, 2022 | 12:15h | UTCCommentaries:
Need for improved global measurement of early childhood respiratory syncytial virus disease – The Lancet (free registration required)
RSV kills 100,000 kids under age 5 a year worldwide – CHEST Physician
A comprehensive evaluation of COVID-19 policies and outcomes in 50 countries and territories.
27 May, 2022 | 12:11h | UTC
Covid-19: Vaccine effectiveness wanes more rapidly for cancer patients, study finds.
27 May, 2022 | 12:04h | UTCCommentary: Covid-19: Vaccine effectiveness wanes more rapidly for cancer patients, study finds – The BMJ
Top studies of 2021 relevant to primary care.
26 May, 2022 | 10:55h | UTCTop studies of 2021 relevant to primary care: From the PEER team – Canadian Family Physician
Study reports first use of antivirals in monkeypox patients.
26 May, 2022 | 11:27h | UTCNews Release: Study reports first use of antivirals in monkeypox patients – Lancet
Original Study: Clinical features and management of human monkeypox: a retrospective observational study in the UK – The Lancet Infectious Diseases
Commentary: Antiviral drug may limit monkeypox symptom duration, infectiousness – CIDRAP
Commentary from one of the author on Twitter (thread – click for more)
Clinical features and management of human monkeypox: a retrospective observational study in the UK https://t.co/0nUtw3lEDn
— Jake Dunning (@OutbreakJake) May 24, 2022
Study Commentary: Long COVID risk falls only slightly after vaccination, huge study shows.
26 May, 2022 | 11:25h | UTCCommentary: Long COVID risk falls only slightly after vaccination, huge study shows – Nature
Original Study: Long COVID after breakthrough SARS-CoV-2 infection – Nature Medicine
Commentary from the author on Twitter (thread – click for more)
The latest from our team in @NatureMedicine
Does vaccination protect from #LongCovid?
Vaccines modestly reduce but do not eliminate risk of Long Covid @VAResearch @vahsrd @WUSTLmed @WUSTLnews @VREFSTL@Biostayan @BCBowe https://t.co/UEexmL8svS
A thread 🧵
— Ziyad Al-Aly, MD (@zalaly) May 25, 2022
Cohort Study: Trajectory of long covid symptoms after covid-19 vaccination.
26 May, 2022 | 11:23h | UTCTrajectory of long covid symptoms after covid-19 vaccination: community based cohort study – The BMJ
Editorial: Are vaccines a potential treatment for long covid? – The BMJ
News Release: Vaccination after SARS-CoV-2 infection linked to a decrease in long covid symptoms – BMJ Newsroom
Commentary on Twitter
LONG COVID: Number of well controlled studies (controls means comparison group of 1) unvaccinated and 2) those who have never had COVID) that show vaccination works to reduce or eliminate long COVID symptoms increasing. BMJ below + biggest from Israel herehttps://t.co/jtZ6aoDmFA https://t.co/n5oDs0Zxe9
— Monica Gandhi MD, MPH (@MonicaGandhi9) May 19, 2022
Cohort Study: Protection and waning of natural and hybrid immunity to SARS-CoV-2.
26 May, 2022 | 11:07h | UTCProtection and Waning of Natural and Hybrid Immunity to SARS-CoV-2 – New England Journal of Medicine
Editorial: Audio Interview: Waning Immunity against Covid-19
Commentary on Twitter
Protection against SARS-CoV-2 waned over time in both vaccinated and previously infected persons; an additional vaccine dose restored protection, find investigators from Israel. https://t.co/617uBmWu8l pic.twitter.com/yiDnBbCuQ5
— NEJM (@NEJM) May 25, 2022
Test-negative, case–control study: effectiveness of homologous and heterologous Covid-19 boosters against Omicron.
26 May, 2022 | 10:59h | UTC
Navigating financial toxicity in patients with cancer: A multidisciplinary management approach.
26 May, 2022 | 10:57h | UTCRelated:
Not Just Nausea And Vomiting: Cancer Docs Now Worry About ‘Financial Toxicity’ – WBUR
Financial Toxicity and Cancer Treatment (PDQ®) – National Institute of Cancer
The Lancet Series: Urban design, transport, and health.
26 May, 2022 | 10:49h | UTCHomepage: Urban design, transport, and health – The Lancet Global Health
Series:
Commentaries:
Creating healthy and sustainable cities: what gets measured, gets done
Urban design is key to healthy environments for all
Measuring what matters: supporting cities in tackling climate and health challenges
The future is urban: integrated planning policies can enable healthy and sustainable cities
Commentary on Twitter
Delighted to announce the publication of our Series on urban design, transport, and health. Visit the hub page for the full Series, Comments, and added extras: https://t.co/dQrsK4jrGe pic.twitter.com/AAi9BeuRhy
— The Lancet Global Health (@LancetGH) May 11, 2022
Characterizing and quantifying low-value diagnostic imaging internationally: a scoping review.
26 May, 2022 | 10:48h | UTC
Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
25 May, 2022 | 11:51h | UTCNews Release: Worldwide shortage of health workers threatens effective health coverage – Institute for Health Metrics and Evaluation
Commentaries on Twitter
Considerable expansion of the world's health workforce is needed to reach targets for #UHC—new #GBDStudy estimates a shortage of 43 million health workers in 2019.
More: https://t.co/FknaY0Onzl @IHME_UW pic.twitter.com/sydiV2Ze1e
— The Lancet (@TheLancet) May 24, 2022
🆕 IHME #GBDStudy reveals that more than 43 million additional health workers are needed globally and ensure all people worldwide have access to the health services they need. #HRH #UHC
Read study here »https://t.co/op3iTNZHtJ pic.twitter.com/LkU3V5tFFN— Institute for Health Metrics and Evaluation (IHME) (@IHME_UW) May 23, 2022
RCT: The addition of Metformin to standard therapy did not improve outcomes in patients with breast cancer.
25 May, 2022 | 11:49h | UTCEffect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial – JAMA (free for a limited period)
Editorial: Who Will Benefit From Metformin? – JAMA Oncology
Retrospective Cohort Study: The incidence of ischemic stroke in patients with asymptomatic severe carotid stenosis (70% to 99%) without surgical intervention was 4.7% over 5 years.
25 May, 2022 | 11:48h | UTCIncidence of Ischemic Stroke in Patients With Asymptomatic Severe Carotid Stenosis Without Surgical Intervention – JAMA (free for a limited period)
News Release: Low stroke risk in patients with very narrowed neck arteries – Kaiser Permanente
USPSTF Recommendation Statement: The current evidence is insufficient to make a recommendation about screening for primary open-angle glaucoma in adults.
25 May, 2022 | 11:46h | UTCEditorials:
Identifying Glaucoma in Primary Care Offices – JAMA Ophthalmology
Evidence Report: Screening for Glaucoma in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA
Patient Page: Screening for Primary Open-Angle Glaucoma – JAMA
Author Interview: USPSTF Recommendations: Screening for Primary Open-Angle Glaucoma and Screening for Impaired Visual Acuity in Older Adults
USPSTF Recommendation Statement: The current evidence is insufficient to make a recommendation about screening for impaired visual acuity in older adults.
25 May, 2022 | 11:44h | UTCEditorials:
Visual Acuity Screening in Older Adults – JAMA Ophthalmology
Screening for Impaired Visual Acuity in Older Adults – JAMA
Evidence Report: Screening for Impaired Visual Acuity in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA
Patient Page: Screening for Impaired Visual Acuity in Older Adults – JAMA
Author Interview: USPSTF Recommendations: Screening for Primary Open-Angle Glaucoma and Screening for Impaired Visual Acuity in Older Adults – JAMA
Effectiveness of CoronaVac in children 3 to 5 years during the SARS-CoV-2 Omicron outbreak in Chile.
25 May, 2022 | 11:42h | UTC
RCT: Baricitinib vs. dexamethasone for adults hospitalized with COVID-19.
25 May, 2022 | 11:38h | UTC
Commentary on Twitter
💥Just Out
ACTT-4 Trial👉First Double Placebo-Controlled Double-Blind Randomized-Stratified Head-to-Head#DEXAMETHASONE vs #BARICITINIB for hospitalized pts w/#COVID19 Low/High-Flow/NIV
Relevant👉Patient Care/Public Health/Guidelines
Our results
👇https://t.co/4Tmue7HK7V
🧵1/4 pic.twitter.com/aF1Y7BAdu3— Andre Kalil, MD MPH (@DrAndreKalil) May 24, 2022